Edwards Lifesciences Corporation (EW) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 6.23B | 6.74B | 6.36B | 6.58B | 6.21B | 6.29B | 6.73B | 4.52B | 4.17B | 4.04B | 4.07B | 3.65B |
| Cash & Short-Term Investments | 3.67B | 4.23B | 3.84B | 4.06B | 3.9B | 3.98B | 4.45B | 1.99B | 1.7B | 1.63B | 1.86B | 1.51B |
| Cash Only | 2.45B | 2.94B | 2.69B | 3.27B | 3.14B | 3.05B | 3.68B | 1.64B | 1.22B | 1.13B | 1.41B | 1.04B |
| Short-Term Investments | 1.23B | 1.29B | 1.16B | 789.4M | 757.9M | 930.7M | 769.7M | 345.3M | 473M | 500.5M | 453.8M | 466.7M |
| Accounts Receivable | 973M | 912.1M | 892.8M | 902.6M | 751.9M | 727.4M | 811.5M | 834.4M | 876.9M | 828.1M | 802.1M | 816.9M |
| Days Sales Outstanding | 51.46 | 52.9 | 53.18 | 49.13 | 47.12 | 51.08 | 55.9 | 56.18 | 58.33 | 59.21 | 59.9 | 56.06 |
| Inventory | 1.12B | 1.13B | 1.14B | 1.14B | 1.11B | 1.09B | 1.1B | 1.02B | 1.21B | 903.5M | 1.03B | 980.2M |
| Days Inventory Outstanding | 281.2 | 306.19 | 304.17 | 299.56 | 328.34 | 344.91 | 372.5 | 341.02 | 331.98 | 354.79 | 340.12 | 318.32 |
| Other Current Assets | 328.5M | 338.8M | 358M | 360.7M | 337.1M | 374.4M | 251M | 556.9M | 250.6M | 542.5M | 235.8M | 217.4M |
| Total Non-Current Assets | 7.09B | 6.96B | 6.91B | 6.91B | 6.81B | 6.77B | 6.24B | 5.58B | 5.57B | 5.33B | 5.3B | 5.36B |
| Property, Plant & Equipment | 1.92B | 1.91B | 1.84B | 1.83B | 1.8B | 1.78B | 1.78B | 1.73B | 1.87B | 1.68B | 1.77B | 1.75B |
| Fixed Asset Turnover | 0.86x | 0.84x | 0.85x | 0.85x | 0.79x | 0.78x | 0.77x | 0.77x | 0.75x | 0.73x | 0.71x | 0.74x |
| Goodwill | 1.82B | 1.77B | 1.77B | 1.78B | 1.78B | 1.78B | 1.61B | 1.15B | 1.25B | 1.15B | 1.3B | 1.3B |
| Intangible Assets | 1.23B | 1.13B | 1.13B | 1.17B | 1.17B | 1.18B | 956.1M | 417.1M | 446.8M | 399.4M | 429.8M | 431.4M |
| Long-Term Investments | 838.1M | 773.9M | 274.7M | 298.5M | 277.9M | 307.9M | 319.6M | 353.3M | 455.6M | 583.9M | 704.6M | 856.2M |
| Other Non-Current Assets | 186.4M | 234.9M | 799.6M | 755.8M | 755.1M | 732.4M | 694M | 1.1B | 767.6M | 774.3M | 447.4M | 412.1M |
| Total Assets | 13.32B | 13.7B | 13.27B | 13.49B | 13.02B | 13.06B | 12.97B | 10.1B | 9.74B | 9.36B | 9.37B | 9B |
| Asset Turnover | 0.12x | 0.12x | 0.12x | 0.12x | 0.11x | 0.11x | 0.12x | 0.14x | 0.14x | 0.14x | 0.14x | 0.15x |
| Asset Growth % | 2.3% | 4.92% | 2.32% | 33.56% | 33.75% | 39.43% | 38.42% | 12.16% | 12.54% | 12.91% | 8.48% | 6.87% |
| Total Current Liabilities | 1.41B | 1.81B | 1.59B | 1.4B | 1.39B | 1.51B | 1.94B | 1.22B | 1.11B | 1.2B | 1.24B | 1.16B |
| Accounts Payable | 181.1M | 227.5M | 165M | 162.1M | 172.4M | 197.4M | 172.8M | 185.9M | 212.3M | 186.6M | 190.6M | 193M |
| Days Payables Outstanding | 51.17 | 53.01 | 43.59 | 44.42 | 55.18 | 58.28 | 62.76 | 60.84 | 62.74 | 69.13 | 64.83 | 62.81 |
| Short-Term Debt | 24.3M | 24.5M | 26.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 22.8M | 27.2M | 33.2M | 36.8M | 46.2M | 53.7M | 66M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 710.5M | 874.5M | 796.1M | 546.8M | 399.1M | 442.7M | 377.8M | 409.5M | 252.3M | 530.2M | 360.5M | 344.9M |
| Current Ratio | 4.42x | 3.72x | 4.00x | 4.68x | 4.45x | 4.18x | 3.46x | 3.71x | 3.75x | 3.38x | 3.28x | 3.15x |
| Quick Ratio | 3.63x | 3.09x | 3.29x | 3.87x | 3.66x | 3.45x | 2.89x | 2.87x | 2.67x | 2.62x | 2.45x | 2.30x |
| Cash Conversion Cycle | 281.48 | 306.07 | 313.76 | 304.27 | 320.28 | 337.71 | 365.63 | 336.36 | 327.57 | 344.87 | 335.19 | 311.57 |
| Total Non-Current Liabilities | 1.58B | 1.55B | 1.48B | 1.48B | 1.44B | 1.49B | 1.42B | 1.38B | 1.44B | 1.45B | 1.4B | 1.4B |
| Long-Term Debt | 598.5M | 598.3M | 598.2M | 598M | 597.8M | 597.7M | 597.5M | 597.3M | 597.2M | 597M | 596.8M | 596.7M |
| Capital Lease Obligations | 80.1M | 82.6M | 75.3M | 78.7M | 77.9M | 78.9M | 85M | 74.2M | 77.2M | 65.2M | 70M | 63.5M |
| Deferred Tax Liabilities | 0 | 0 | 442.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 906.1M | 865M | 362.8M | 800.8M | 760.2M | 810.6M | 733.2M | 706.2M | 764.7M | 786.2M | 738M | 740.1M |
| Total Liabilities | 2.99B | 3.36B | 3.07B | 2.88B | 2.83B | 2.99B | 3.36B | 2.59B | 2.55B | 2.64B | 2.64B | 2.56B |
| Total Debt | 702.9M | 705.4M | 700.3M | 702.6M | 699.4M | 700M | 706.7M | 693M | 699.2M | 685.1M | 691.1M | 684.5M |
| Net Debt | -1.74B | -2.23B | -1.99B | -2.57B | -2.44B | -2.35B | -2.97B | -951.5M | -525.4M | -447.2M | -719M | -358.1M |
| Debt / Equity | 0.07x | 0.07x | 0.07x | 0.07x | 0.07x | 0.07x | 0.07x | 0.09x | 0.10x | 0.10x | 0.10x | 0.11x |
| Debt / EBITDA | 1.27x | 1.71x | 1.51x | 1.50x | 1.62x | 1.97x | 1.84x | 1.71x | 1.77x | 1.74x | 1.80x | 1.68x |
| Net Debt / EBITDA | -3.14x | -5.41x | -4.28x | -5.48x | -5.66x | -6.60x | -7.71x | -2.35x | -1.33x | -1.14x | -1.88x | -0.88x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 10.33B | 10.34B | 10.21B | 10.61B | 10.19B | 10.06B | 9.61B | 7.5B | 7.19B | 6.72B | 6.73B | 6.45B |
| Equity Growth % | 1.33% | 2.73% | 6.18% | 41.33% | 41.82% | 49.76% | 42.88% | 16.41% | 18.55% | 15.72% | 8.19% | 8.46% |
| Book Value per Share | 17.78 | 17.77 | 17.42 | 18.04 | 17.34 | 17.04 | 16.07 | 12.42 | 11.90 | 11.07 | 11.04 | 10.56 |
| Total Shareholders' Equity | 10.33B | 10.34B | 10.21B | 10.55B | 10.13B | 10B | 9.55B | 7.44B | 7.12B | 6.65B | 6.66B | 6.38B |
| Common Stock | 660M | 658.7M | 658.2M | 657.6M | 655.9M | 654.8M | 654.3M | 653.5M | 651.8M | 650.5M | 649.9M | 649.1M |
| Retained Earnings | 14.62B | 14.24B | 14.15B | 13.86B | 13.53B | 13.17B | 12.78B | 9.71B | 9.34B | 8.99B | 8.62B | 8.24B |
| Treasury Stock | -7.51B | -7.09B | -7.05B | -6.46B | -6.45B | -6.19B | -6.09B | -5.18B | -5.02B | -5.02B | -4.58B | -4.4B |
| Accumulated OCI | -221.3M | -238.3M | -250.4M | -264.1M | -254.5M | -244.5M | -252.5M | -220.2M | -233.3M | -242.8M | -250.1M | -255.5M |
| Minority Interest | 0 | 0 | 0 | 61.2M | 62.9M | 64.5M | 65.8M | 67.2M | 68.5M | 69.4M | 69.6M | 70.8M |